Keybanc raises Hinge Health price target to $90
Keybanc analyst Scott Schoenhaus maintains an Overweight rating on Hinge Health and raises the price target from $75 to $90, signaling strong confidence in the company's growth prospects.
*this image is generated using AI for illustrative purposes only.
Keybanc analyst Scott Schoenhaus has maintained an Overweight rating on Hinge Health, raising the price target to $90 from $75. The adjustment reflects increased confidence in the company's market position and growth trajectory.
Rating and Price Target
The revised price target of $90 represents a significant increase from the previous target of $75. This move underscores the analyst's positive outlook on Hinge Health's future performance.
| Metric | Value |
|---|---|
| Rating | Overweight |
| Previous Price Target | $75 |
| New Price Target | $90 |
Hinge Health operates in the digital health sector, focusing on musculoskeletal care. The Overweight rating suggests the stock is expected to outperform the broader market.
What specific market trends or competitive advantages are driving Hinge Health's growth trajectory?
How might this price target adjustment influence investor sentiment toward the digital health sector?
What are the potential risks or challenges Hinge Health could face in maintaining its market position?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
